Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series

Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series

Immune checkpoint inhibitors (ICIs) targeting cytotoxic Tlymphocyte associated protein-4 (CTLA-4), programmed cell death protein-1 (PD-1), and its ligand PD-L1 are established cancer immunotherapies for solid tumor and hematologic malignancies. These therapies are involved in immune-related adverse...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonella Laria (Author), Alfredomaria Lurati (Author), Laura Castelnovo (Author), Antonio Tamburello (Author), Paola Maria Faggioli (Author), Antonino Mazzone (Author)
Format: Book
Published: Verduci Editore, 2021-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items